Multiple Sclerosis News Today Forums › Forums › Treating MS › MS Medications › FDA delays decision on Ofatumumab

Tagged: 

  • MS Medications

    FDA delays decision on Ofatumumab

    Posted by ed-tobias on June 5, 2020 at 10:29 am

    It’ll be a little longer before the Food and Drug Administration decides whether it will approve Ofatumumab. That decision is now hoped for by September. Ofatumumab would be the only a monoclonal antibody therapy available as a self-injection. The rest are infusions. Sound like something you’d ask your neuro about?

    ed-tobias replied 3 years, 10 months ago 1 Member · 0 Replies
  • 0 Replies

Sorry, there were no replies found.

Log in to reply.

Start of Discussion
0 of 0 replies June 2018
Now

Report

Harassment or bullying behavior
Contains mature or sensitive content
Contains misleading or false information
Contains abusive or derogatory content
Contains spam, fake content or potential malware

Block Member?

Please confirm you want to block this member.

You will no longer be able to:

  • See blocked member's posts
  • Mention this member in posts
  • Invite this member to groups
  • Message this member
  • Add this member as a connection

Please note: This action will also remove this member from your connections and send a report to the site admin. Please allow a few minutes for this process to complete.

Report

You have already reported this .